Figures & data
Figure 1 Representative profile of the changes in the absorbance of mitochondria isolated from rats treated with: graded doses of lipopolysaccharide to induce inflammation in the liver (A), ibuprofen as an anti-inflammatory drugn (B), and graded doses of the n-hexane fraction of A. boonei (C).
![Figure 1 Representative profile of the changes in the absorbance of mitochondria isolated from rats treated with: graded doses of lipopolysaccharide to induce inflammation in the liver (A), ibuprofen as an anti-inflammatory drugn (B), and graded doses of the n-hexane fraction of A. boonei (C).](/cms/asset/a8529821-2c0d-4d82-bc3d-5b6d3c6abe3e/djir_a_12190209_f0001_c.jpg)
Figure 2 Influence of the n-hexane fraction of A. boonei on F0F1 ATPase activity in lipopolysaccharide-induced hepatic inflammation in rats. *P<0.05; **P<0.01; ***P<0.001 LPS control versus test groups.
![Figure 2 Influence of the n-hexane fraction of A. boonei on F0F1 ATPase activity in lipopolysaccharide-induced hepatic inflammation in rats. *P<0.05; **P<0.01; ***P<0.001 LPS control versus test groups.](/cms/asset/bbb97cc5-be67-4e3f-a560-901326fcaf0f/djir_a_12190209_f0002_b.jpg)
Figure 3 Mitigating effects of the n-hexane fraction of A. boonei on increase in interleukin 1 beta (A) and interleukin 6 (B) induced by lipopolysaccharide. Where ns= not significant; ****=P<0.0001 LPS control versus test groups.
![Figure 3 Mitigating effects of the n-hexane fraction of A. boonei on increase in interleukin 1 beta (A) and interleukin 6 (B) induced by lipopolysaccharide. Where ns= not significant; ****=P<0.0001 LPS control versus test groups.](/cms/asset/c21ae9ef-49d3-4c37-afa4-0641723861dc/djir_a_12190209_f0003_b.jpg)
Figure 4 Effects of the administration of the n-hexane fraction of A. boonei to rats challenged with lipopolysaccharide on TNF-α (A), creatine kinase (B) and C-reactive protein (C). *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001 LPS control versus test groups.
![Figure 4 Effects of the administration of the n-hexane fraction of A. boonei to rats challenged with lipopolysaccharide on TNF-α (A), creatine kinase (B) and C-reactive protein (C). *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001 LPS control versus test groups.](/cms/asset/417ed69d-2bb6-4a8c-a58e-513bc90fdf13/djir_a_12190209_f0004_b.jpg)
Figure 5 Mitigating effect of the n-hexane fraction of Alstonia boonei on hepatotoxic effects of lipopolysaccharide using aspartate (A) and alanine (B) aminotransferases as well as gamma glutamyl transferase (C). *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001 treated groups vs lipopolysaccharide negative control.
![Figure 5 Mitigating effect of the n-hexane fraction of Alstonia boonei on hepatotoxic effects of lipopolysaccharide using aspartate (A) and alanine (B) aminotransferases as well as gamma glutamyl transferase (C). *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001 treated groups vs lipopolysaccharide negative control.](/cms/asset/ab6e51bf-b7d1-43ea-85ff-dc58e9f1c383/djir_a_12190209_f0005_b.jpg)
Table 1 UHPLC-MS Report of the n-Hexane Fraction of A. boonei